Exposure to duloxetine during pregnancy and risk of congenital malformations and stillbirth: A nationwide cohort study in Denmark and Sweden

BACKGROUND: The prevalence of depression and the exposure to antidepressants are high among women of reproductive age and during pregnancy. Duloxetine is a selective serotonin-norepinephrine reuptake inhibitor (SNRI) approved in the United States and Europe in 2004 for the treatment of depression. F...

Descripción completa

Detalles Bibliográficos
Autores principales: Ankarfeldt, Mikkel Zöllner, Petersen, Janne, Andersen, Jon Trærup, Li, Hu, Motsko, Stephen Paul, Fast, Thomas, Hede, Simone Møller, Jimenez-Solem, Espen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8654175/
https://www.ncbi.nlm.nih.gov/pubmed/34807906
http://dx.doi.org/10.1371/journal.pmed.1003851

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8654175/
https://www.ncbi.nlm.nih.gov/pubmed/34807906
http://dx.doi.org/10.1371/journal.pmed.1003851

Ejemplares similares